DFX Intelligence
Family Office Intelligence
A continuously maintained graph of U.S. family offices: identity, team, observed investments, public holdings, relationships and dated signals of change. Facts, inferences and estimates are labelled as such, with the source and the date, on every row. Unknown is printed as unknown.
Family office profile
Christian Angermayer's Family Office
Malta (Sliema; later Birkirkara, Centris Business Gateway)Single family office (confirmed)identity confidence 90%Top 500 by research priorityapeiron-investments.com
Why this class: Apeiron Investment Group's own Schedule 13D says its principal business is serving as an asset manager and as the family office of Christian Angermayer..
Verified Sep 13, 2026 (5 days ago)
Last observed Sep 16, 2026 · 25 observations · 3 sources
3 people · 15 investments · 0 public positions · 10 events
Identity
90
high
Data depth
70
high
Freshness
100
high
Active deployment
100
high
Direct investing
85
high
External managers
40
elevated
Private markets
60
high
Sponsor-friendly
60
high
Real estate
0
low
Co-investment
100
high
Contactability
40
elevated
Mandate confidence
90
high
Twelve separate dimensions, each 0 to 100 from listed components. There is no single family office score; the components are in the evidence section.
Overview
Profile completeness 78% (high value, high value deep; the most valuable missing fact is aum evidence)
identityclassificationwealth origincapital-scale evidencepeoplecontactsmandatedirect investmentsfund relationshipsco-investorssponsor relationshipsreal estatepublic holdingsrecent eventsprovenancefreshness
- Classification
- Single family office (confirmed)
- Description
- Uses secured facility borrowing to fund stakes (Alien Capital Limited; Berenberg) with pledge and personal guarantee
- Headquarters
- Malta (Sliema; later Birkirkara, Centris Business Gateway)
- Office address
- unknown
- Business phone
- unknown
- Website
- apeiron-investments.com
- Year established
- unknown
- Assets under management
- unknown
- Capital scale
- Reported office AUM: unknown. No public number of any kind.
Classification history
- Sep 13, 2026Single family office (confirmed) 90%Apeiron Investment Group's own Schedule 13D says its principal business is serving as an asset manager and as the family office of Christian Angermayer.Factverifiedsec.gov“The principal business of Apeiron is serving as an asset manager and as the family office of Mr. Angermayer.”
- Sep 12, 2026Single family office (probable) 70%a press release by Enhanced describes it as a single family office (cited)Fact
Family and wealth origin
- Family served
- Christian Angermayer (majority shareholder of Apeiron)
- Source of wealth
- Co-founded Ribopharma AG (2000), merged with Alnylam Pharmaceuticals in 2003
- Operating company origin
- unknown
Team
| Person | Title | Responsibility | Business contact | Source |
|---|---|---|---|---|
| Christian Angermayer family | Founder and owner; majority shareholder of Apeiron | Family principal · investment decisions | email: christian.angermayer@apeiron-investments.com (verified by provider, Sep 15, 2026) | sec.gov Fact |
| Mario Frendo | Sole director and Senior Legal Counsel, Apeiron | Leadership · investment decisions | none on record | sec.gov Fact |
| Fabian Hansen | Co-founder, Presight Capital (reporting person for Presight Capital Fund II) | Venture · investment decisions | none on record | en.wikipedia.org Fact |
Former
Julien Hoefer, Director and managing director, Apeiron Investment Group Ltd (2022); lawyer, until Sep 13, 2026
Jefim Gewiet, Director and managing director, Apeiron Investment Group Ltd (2022); financial advisor, until Sep 13, 2026
Office contact points
Investment mandate
1 investments on the record; last deal 2026-06-15
Stated (their words, cited)
No cited statement of mandate on the record.
Observed (from the investment record)
- States
- none Fact
- Control
- minority (1) Fact
- Sectors
- none Fact
- Subsectors
- none Fact
- Co investors
- Co-Founder (1), CEO Maximilian Martin (1), Global Institutional Investors Management Expects Current Capital Position (1), Christian Angermayer's Family Office Apeiron Investment Group (1) Fact
- Asset classes
- none Fact
- Direct vs fund
- Fund: 0 · Direct: 1 · Real estate: 0 Fact
- Sponsors backed
- none Fact
- Investment count
- 1 Fact
- Investment kinds
- round participation (1) Fact
- First and last deal
- Last: 2026-06-15 · First: 2026-06-15 Fact
- Lead vs participant
- lead (1) Fact
- Disclosed check sizes
- Max: unknown · Min: unknown · Count: 0 Factamounts are only what a source disclosed; never backsolved from a round
Inferred (regulatory shape and team)
Nothing to infer from.
- Invests directly
- Yes; direct investments in private and listed companies across the lifecycle, from incubation to growth
- Allocates to managers
- Anchor LP investments combined with GP stakes in emerging asset managers
- Asset classes
- unknown
- Sectors
- Life sciences (psychedelics, longevity), fintech, crypto, future technologies
- Geography
- Global multi-strategy with primary focus on the US
- Check size
- unknown
Direct investments
| Date | Company | Kind | Sector | Role | Amount | With | Source |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Enhanced Group Inc. (NYSE: ENHA) $50M PIPE | Round participation | Sports and consumer health | lead · minority | $50.0M | Maximilian Martin (co investor) | sec.gov Fact “Financing Led by Christian Angermayer’s Family Office Apeiron Investment Group” |
| Jun 15, 2026 | Enhanced Group | Round participation | unknown | lead · minority | unknown round $50.0M | none named | prnewswire.com Fact “Financing Led by Christian Angermayer's Family Office Apeiron Investment Group with Participation from Co-Founder and CEO Maximilian Martin ” |
| May 7, 2026 | Enhanced Group Inc. working capital note (up to $20.0M line of credit) | Credit | Sports and consumer health | lead | $20.0M | none named | sec.gov Fact “In consideration for Apeiron providing the Issuer with a working capital note” |
| May 7, 2026 | Enhanced Group Inc. (Enhanced Ltd. de-SPAC with A Paradise Acquisition Corp.) | Direct investment | Sports and consumer health | lead · minority | unknown | A SPAC IV (Holdings) Corp. (sponsor) | sec.gov Fact “The securities reported herein were received as part of the Issuer's Business Combination” |
| Feb 14, 2025 | ATAI Life Sciences N.V. (February 2025 registered offering) | Round participation | Psychedelic mental health biotech | participant · minority | $22.8M | none named | sec.gov Fact “Apeiron purchased 10,835,718 Common Shares at an aggregate purchase price of approximately $22,750,000 in the Offering.” |
| Oct 3, 2024 | Bionomics Limited (via Apeiron Presight Capital Fund II) | Venture | Neuropsychiatry biotech | participant · minority | unknown | none named | sec.gov Fact “Presight Capital Fund II, L.P. 2 Check the Appropriate Box” |
| Dec 18, 2018 | Rezolve Limited (pre-SPAC shareholder) | Venture | AI commerce | participant · minority | unknown | none named | sec.gov Fact “that certain Shareholder Deed, dated December 18, 2018, by and between DBLP Sea Cow Limited, Daniel Maurice Wagner, Apeiron Investment Group” |
| n/a | Plasma (XPL) seed round | Venture | Stablecoin blockchain | participant | unknown | Peter Thiel (co investor) | en.wikipedia.org Fact “He invested in its seed round, alongside Thiel” |
| n/a | Rejuveron Life Sciences and Cambrian Biopharma | Venture | Longevity biotech | unknown | unknown | none named | en.wikipedia.org Fact “Through Apeiron, Angermayer has also co-founded or invested in several longevity-focused biotechnology companies, including Rejuveron Life S” |
| n/a | Interactive Strength, Inc. (Forme) investor rights | Venture | Connected fitness | participant · minority | unknown | none named | sec.gov Fact “provided that with respect to Apeiron Investment Group Ltd., Forme Co-Invest I, L.P.” |
| n/a | Sensei Biotherapeutics, Inc. (pre-IPO and IPO shares) | Venture | Immuno-oncology biotech | participant · minority | $27.4M | none named | sec.gov Fact “The Shares purchased by Apeiron were purchased with working capital (which may, at any given time, include margin loans made by brokerage fi” |
| n/a | Alto Neuroscience, Inc. (Series A and B preferred, pre-IPO) | Venture | Precision psychiatry biotech | participant · minority | unknown | none named | sec.gov Fact “The reportable securities are held by Apeiron Investment Group Ltd.” |
| n/a | atai Life Sciences (founded 2018) | Venture | Psychedelic mental health biotech | lead | unknown | none named | en.wikipedia.org Fact “In 2018 he founded atai Life Sciences” |
Fund and manager relationships
- Presight Capital Fund I ($80M) Venture · n/a · $80.0M en.wikipedia.org
- Elevat3 (Apeiron venture vehicle, Peter Thiel anchor) Venture · n/a · amount unknown en.wikipedia.org
Public stakes and holdings
Form 13F holdings
No 13F filing on the record for this office.
Real estate
No documented real estate ownership link. A property is attributed to an office only through a documented control relationship, never from a surname.
Co-investors
| Counterparty | Kind | Shared deals | First, last | Examples | Source |
|---|---|---|---|---|---|
| Peter Thiel | organisation | 2 | undated (historical) | Elevat3 (Apeiron venture vehicle, Peter Thiel anchor), Plasma (XPL) seed round | en.wikipedia.org |
| Maximilian Martin | organisation | 1 | Jun 15, 2026 | Enhanced Group Inc. (NYSE: ENHA) $50M PIPE | sec.gov |
| A SPAC IV (Holdings) Corp. | independent sponsor (sponsor) | 1 | May 7, 2026 | Enhanced Group Inc. (Enhanced Ltd. de-SPAC with A Paradise Acquisition Corp.) | sec.gov |
- Peter Thiel strong (3) Fact en.wikipedia.org
- Peter Thiel strong (3) Fact en.wikipedia.org
- Peter Thiel strong (3) Fact en.wikipedia.org
- Maximilian Martin Jun 15, 2026 recurring (2) Fact sec.gov
- Maximilian Martin Jun 15, 2026 recurring (2) Fact sec.gov
Independent sponsor relationships
Signals and timeline
Most significant first: what kind of change it is, its size, whose change it is, and how recent. 10 events. 13F position changes are under Public stakes and holdings.
- Sep 13, 2026Classification changedChristian Angermayer's Family Office: PROBABLE_SFO -> CONFIRMED_SFO (Apeiron Investment Group's own Schedule 13D says its principal business is serving as an asset manager and as the family office of Christian Angermayer.)ClassificationFactsec.gov
- Jun 15, 2026Office discoveredChristian Angermayer's Family Office named as a single family office on prnewswireDiscoveryFactprnewswire.com
- Jun 15, 2026Direct investmentChristian Angermayer's Family Office invested in Enhanced Group Inc. (NYSE: ENHA) $50M PIPEDirect investmentsFactsec.gov
- May 7, 2026Direct investmentChristian Angermayer's Family Office invested in Enhanced Group Inc. (Enhanced Ltd. de-SPAC with A Paradise Acquisition Corp.)Direct investmentsFactsec.gov
- May 7, 2026New investment vehicleEnhanced Ltd. closes business combination; Apeiron and Enhanced Holdings LP report 24.4% of Class AVehiclesFactsec.gov
- May 7, 2026Direct investmentChristian Angermayer's Family Office invested in Enhanced Group Inc. working capital note (up to $20.0M line of credit)Direct investmentsFactsec.gov
- Feb 14, 2025Direct investmentChristian Angermayer's Family Office invested in ATAI Life Sciences N.V. (February 2025 registered offering)Direct investmentsFactsec.gov
- Oct 3, 2024Direct investmentChristian Angermayer's Family Office invested in Bionomics Limited (via Apeiron Presight Capital Fund II)Direct investmentsFactsec.gov
- Sep 27, 2024Service provider changedBerenberg facility agreement entered (amended 2025)OrganisationFactsec.gov
- Dec 18, 2018Direct investmentChristian Angermayer's Family Office invested in Rezolve Limited (pre-SPAC shareholder)Direct investmentsFactsec.gov
Sources and evidence
Every observation behind this profile: the value, when it was effective, the source, the quote where there is one, and whether it is a fact, an inference or an estimate. 25 shown.
Score components
Freshness
+100 days since the newest source-dated fact or analyst verification (1 days)
Contactability
+30 named decision-makers (Mario Frendo (Sole director and Senior Legal Counsel, Apeiron); Fabian Hansen (Co-founder, Presight Capital (reporting person for Presight Capital Fund II)))
+10 verified business emails (1)
Data confidence
+10 website
+10 description
+10 stated mandate
+10 people
+15 investments
+15 independent sources (3 sources)
Active deployment
+75 dated private investments in last 24 months (Enhanced Group Inc. (Enhanced Ltd. de-SPAC with A Paradise Acquisition Corp.) (2026-05-07); ATAI Life Sciences N.V. (February 2025 registered offering) (2025-02-14); Enhanced Group (2026-06-15); Enhanced Group Inc. (NYSE: ENHA) $50M PIPE (2026-06-15))
+25 a dated private investment in last 12 months (2026-06-15)
Exists confidence
+20 website
+30 independent sources (3 sources)
+30 analyst-verified
Research priority
+15 single family or family investment company
+15 direct investments on record
+10 deployed in last 24 months
+10 independent sponsor relationship
+0 rank (19)
Mandate confidence
+70 mandate supported by observed investments
+20 stated mandate on the record
Identity confidence
+90 classification (CONFIRMED_SFO (Apeiron Investment Group's own Schedule 13D says its principal business is serving as an asset manager and as the family office of Christian Angermayer.))
Real estate propensity
no components; scored 0
Co investment propensity
+80 co-investors on the record (Maximilian Martin; Peter Thiel; Peter Thiel; Peter Thiel; Maximilian Martin)
+20 participant in syndicated rounds
Family identity confidence
+60 wealth origin or operating company on the record
+40 family named (Christian Angermayer (majority shareholder of Apeiron))
+20 family principal on staff
Private markets propensity
+60 private markets investments observed
Current activity confidence
+50 dated private investment in 24 months
+25 a source-dated fact within 12 months (1 days)
External manager propensity
+40 fund or manager relationships
Direct investment propensity
+70 observed direct investments (13 on the record)
+15 direct investment professional on staff
Independent sponsor propensity
+60 sponsor relationships on the record (A SPAC IV (Holdings) Corp.; A SPAC IV (Holdings) Corp.)
| Fact | Value | Effective | Source | Class |
|---|---|---|---|---|
| Allocates to managers | Anchor LP investments combined with GP stakes in emerging asset managers “as well as anchor LP investments combined with GP stakes in emerging asset managers.” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) apeiron-investments.com | Fact |
| Aum stated | Approximately $7 billion, internal and external capital “We currently manage approximately $7 billion, both internal and external capital.” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) apeiron-investments.com | Fact |
| Co invest behavior | Runs co-invest vehicles (Presight Sensei Co-Invest Fund, Apeiron SICAV Co-Investment Fund 3) alongside balance-sheet stakes “By Co-Investment Fund 3, a Sub-Fund of Apeiron SICAV Ltd” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Inference |
| Description | Apeiron Investment Group: discretionary investment firm founded and owned by Christian Angermayer; asset manager and his family office “The principal business of Apeiron is serving as an asset manager and as the family office of Mr. Angermayer.” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Description | Uses secured facility borrowing to fund stakes (Alien Capital Limited; Berenberg) with pledge and personal guarantee “The source of funds for Apeiron's purchase of Common Shares in the Offering was approximately $17,000,000 in proceeds drawn under a facility agreement, dated as of August 9, 2024, as subsequently amen” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Family generation | First generation (founder-entrepreneur) “founded and owned by serial entrepreneur Christian Angermaye” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) apeiron-investments.com | Inference |
| Family served | Christian Angermayer's family | n/a | DFX model output (classification rules, scores, mandates, matches) no URL | Inference |
| Family served | Christian Angermayer (majority shareholder of Apeiron) “Christian Angermayer, as the majority shareholder of Apeiron” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Family wealth estimate | US$1.2 billion (Forbes estimate as of 2025, via Wikipedia) “As of 2025, he is estimated by Forbes to have a net worth of US$1.2 billion.” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) en.wikipedia.org | Fact |
| Geographic mandate | Global multi-strategy with primary focus on the US “we apply a global, multi-strategy investment approach, with a primary focus on the US.” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) apeiron-investments.com | Fact |
| Headquarters | Malta (Sliema; later Birkirkara, Centris Business Gateway) “The principal business address of each of the Reporting Persons is Centris Business Gateway - Level 0/C, Triq is-Salib tal-Imriehel (Zone 3, Central Business District) Birkirkara, CBD 3020, Malta.” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Invests directly | Yes; direct investments in private and listed companies across the lifecycle, from incubation to growth “Through our proprietary balance sheet, our direct investment approach encompasses the entire company lifecycle” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) apeiron-investments.com | Fact |
| Legal entity | Apeiron Investment Group Ltd. (Malta private limited company) “Apeiron Investment Group, Ltd., a Malta private limited compan” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Legal entity | Presight Co-Invest Management, L.L.C. (wholly owned GP subsidiary) and Presight Sensei Co-Invest Fund, L.P. “The principal business of Presight Co-Invest Management, which is a wholly owned subsidiary of Apeiron, is serving as the general partner of Presight Co-Invest.” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Legal entity | Apeiron Presight Capital Fund II, L.P.; Apeiron SICAV Ltd (Co-Investment Fund 3 sub-fund; re.Mind Capital Fund ONE) “By Co-Investment Fund 3, a Sub-Fund of Apeiron SICAV Ltd Series A Preferred Stock Common Stock 287015 I By Apeiron SICAV Ltd. in respect of re.Mind Capital Fund ONE” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Legal entity | Enhanced Holdings GP and Enhanced Holdings LP (Cayman Islands) “Enhanced Holdings GP and Enhanced Holdings LP are organized under the laws of the Cayman Islands.” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Office type (stated) | single_family_office “The principal business of Apeiron is serving as an asset manager and as the family office of Mr. Angermayer.” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Office type (stated) | single_family_office | Jun 15, 2026 | PR Newswire releases that name a family office (discovery and investment records, quoted) prnewswire.com | Fact |
| Satellite office | Teams in New York, London, Berlin, Abu Dhabi and Malta “With teams in New York, London, Berlin, Abu Dhabi, and Malta, we apply a global, multi-strategy investment approach, with a primary focus on the US.” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) apeiron-investments.com | Fact |
| Sectors | Life sciences (psychedelics, longevity), fintech, crypto, future technologies “his family office and merchant-banking business, which invests across life sciences, financial technology, cryptocurrency and future technologies.” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) en.wikipedia.org | Fact |
| Stage preference | Incubation through growth stage plus listed companies “from incubating and accelerating breakthrough ideas to scaling growth-stage businesses” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) apeiron-investments.com | Fact |
| Source of wealth | Co-founded Ribopharma AG (2000), merged with Alnylam Pharmaceuticals in 2003 “In 2003, Ribopharma merged with Massachusetts -based Alnylam Pharmaceuticals , which later went public . The business made Angermayer a multimillionaire at age 25.” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) en.wikipedia.org | Fact |
| Website | apeiron-investments.com | Sep 16, 2026 | DFX model output (classification rules, scores, mandates, matches) apeiron-investments.com | Inference |
| Website read | site-fo-3 | Sep 16, 2026 | Family office and investment company websites (about, team, portfolio, news pages) apeiron-investments.com | Fact |
| Website search | not_found | Sep 14, 2026 | DFX model output (classification rules, scores, mandates, matches) no URL | Inference |